Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study

Condition(s) studied

Investigational drug(s) / intervention(s)

Standard Medical Therapy: Routine pharmacological treatments including antiplatelets, antihypertensives

Revascularization Procedures: Surgical or interventional procedures such as PCI (Percutaneous Coronary Intervention) or stent thrombectomy for stroke.

Lifestyle Modification: Habitual factors including smoking cessation, physical activity, and dietary habits monitored during the follow-up.

Study summary

This study aims to establish a comprehensive, long-term clinical registry infrastructure for heart and brain vascular diseases (cardiovascular diseases and stroke) at Samsung Medical Center. In South Korea, these diseases are a leading cause of death, with a rapidly increasing burden due to an aging population and changing lifestyles. Despite this, there is a lack of large-scale, systematic data specifically focused on the long-term clinical course and unique characteristics of Korean patients.

The central hypothesis of this study is that the establishment of a standardized registry infrastructure-integrating both retrospective (historical) and prospective (future) data collection-will provide a more accurate and comprehensive understanding of the natural history and risk factors of heart and brain vascular diseases in the Korean population than currently available fragmented data. By combining existing medical records with ongoing patient follow-up, this infrastructure will serve as a critical scientific platform for developing personalized prevention and precision medicine strategies.

By building this organized data collection system, the study will:

Construct a robust infrastructure to collect uniform, high-quality clinical data, encompassing both past medical history (retrospective) and future clinical progress (prospective) from a large population of Korean patients.

Monitor long-term health outcomes and the progression of diseases by tracking patients over many years.

Analyze the interaction between various risk factors and patient outcomes to identify population-specific patterns.

Create a scalable platform that can integrate advanced technologies, such as multi-omics and digital health tools, for future research.

Ultimately, this integrated registry infrastructure is expected to provide the essential scientific evidence needed to optimize clinical guidelines and improve the long-term quality of life for patients with heart and brain vascular diseases in Korea.

Eligibility

Primary outcome measure(s)

• Incidence of Major Adverse Cardio-Cerebrovascular Events (MACCE) — Up to 20 years (from the date of enrollment until the end of the follow-up period)

Trial sites (1)

More Samsung Medical Center trials in South Korea